Induction of interleukin-6 after stimulation of human B-cell CD21 by epstein-barr virus glycoproteins gp350 and gp220

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 570-575

  Tanner, Jerome E ^a,b   Alfieri, Caroline ^c   Chatila, Talal A ^d   Diaz Mitoma, Francisco ^a,b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; INTERLEUKIN 6; IONOMYCIN; MONOCLONAL ANTIBODY; PHORBOL DIBUTYRATE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; RNA; VIRUS GLYCOPROTEIN;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS LINKING; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CELLS, CULTURED; HERPESVIRUS 4, HUMAN; HUMAN; INTERLEUKIN-6; PHORBOL 12,13-DIBUTYRATE; RECEPTORS, COMPLEMENT 3D; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS; VIRAL MATRIX PROTEINS;

EID: 0029656148     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.570-575.1996     Document Type: Article

References (46)

1. Akira, S., T. Taga, and T. Kishimoto. 1993. Interleukin 6 in biology and medicine. Adv. Immunol. 54:1-48
2. Alfieri, C., M. Birkenbach, and E. Kieff. 1991 Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595-608.
3. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold of antigen receptor stimulation of B lymphocytes. Science 256:105-107.
4. Carter, R. H., M. O. Spycher, Y. C. Ng. R. Hoffman, and D. T. Fearon. 1988 Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457-463.
5. Cheung, R. K., and H. M. Dosch. 1991. The tyrosine kinase lck is critically involved in the growth transformation of human B lymphocytes. J. Biol Chem 266:8667-8670.
6. DeFranco, A. L. 1994. B lymphocyte activation, p. 505-529. In W. Paul (ed), Fundamental immunology, 3rd ed. Raven Press, New York.
7. Demaret, J. P., S. Brunis, J. P. Ballini, and P. Vigny. 1989. Geometry of intercalation of psoralens in DNA approached by molecular mechanism Photochem. Photobiol. 50:7-21.
8. Gold, M. R., and A. L. DeFranco. 1994. Biochemistry of B lymphocyte activation Adv. Immunol. 55:221-295.
9. Gordon, J., S. C. Ley, M. D. Mclamed, P. Aman, and N. C. Hughes-Jones. 1984. Soluble factor requirements for autostimulation of B lymphoblasts immortalized by Epstein-Barr virus. J. Exp. Med. 159:1554-1559.
10. Gordon, J., L. Walker, G. Guy, G. Brown, M. Rowe, and A. Rickinson. 1986. Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B cell growth. Immunology 58:591-595.
11. Groene, W. S., and R. D. Shaw. 1992. Psoralen preparation of antigenically intact noninfectious rotavirus particles. J. Virol. Methods 38:93-102.
12. Hoffman, G. J., G. L. Sondra, and S. D. Hayward. 1980. Monoclonal against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc. Natl Acad. Sci. USA 77:2979-2983.
13. ras. Eur. J. Immunol. 23:131-135.
14. Janicot, M., J. R. Flores-Riveros, and M. D. Lane. 1991. The insulin-like growth factor 1 (IGF-1) receptor is responsible for mediating the effects of insulin. IGF-1 and IGF-2 in Xenopus laevis oocytes. J Biol. Chem 266:9389-9391.
15. Katria, A., K. A. Knox, M. Finney, R. H. Michell, M. Wakeman, and J. Gordon. 1993. Inhibition by glucocorticoid and staurosporine of IL-4-dependent CD23 production m B lymphocytes is reversed on engaging CD40. Clin. Exp. Immunol. 92:347-352.
16. Kawakami, T., N. Inagaki, M. Takei, H. Fukamachi, K. M. Coggeshall, K. Ishizaka, and T. Ishizaka. 1992. Tyrosine phosphorylation is required for mast cell activation. J. Immunol. 148:3513-3519.
17. Kawasaki, E. 1990. Amplification of RNA, p 21-27. In M. A. Innis. D. H Gelfand, J. J. Sninisky, and T J White (ed). PCR protocols: a guide to methods and applications. Academic Press, San Diego, Calif.
18. Kieff, E., and D. Liebowitz. 1990. Epstein-Barr virus and its replication, p 897-928. In B. N. Fields, D. M. Knipe, R. M Chanock, J L. Melnick B. Roizman, and R. E Shope (ed.), Virology, 2nd ed. Raven Press, New York
19. Kurvilla, A., G. Putcha, E. Poulos, and W. T. Shearer. 1993. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line. J. Immunol. 151:637-648
20. Luxembourg, A. T., and N. R. Cooper. 1994. Modulation of signalling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J Immunol 153:4448-4457.
21. Martin, D. R., A. Yuryev, K. R. Kalli, D. T. Fearon, and J. M. Ahearn. 1991 Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2. J. Exp. Med. 174:1299-1311
22. Matsumoto, K., D. R. Martin, R. H. Carter, L. B. Klickstein, J. A. Ahearn, and D. T. Fearon. 1993. Functional dissection of the CD21/CD19.TAPA-1/leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407-1417.
23. Miller, G. 1985 Epstein-Barr virus, p. 563-589. In B. N. Fields, D. M. Knipe, R M Chanock, J. L. Melnick, B. Roizman, and R. E Shope (ed.), Virology Raven Press, New York.
24. Morrissey, S. H. 1981. Silver stain for proteins in polyacrylamide gels a modified procedure with enhanced uniform sensitivity. Anal Biochem 117:307-310.
25. Murphy, L. D., C. E. Herzog, J. B. Rodick, A. T. Fojo, and S. C. Bates. 1990. Use of polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 29:10351-10356.
26. Nordan, R. P. 1991 Measurement of mouse and human interleukin-6, p. 6.1.1-6.1.5. In J. E. Coligan. A. M. Kruisbeck, D. H. Shevack, E M. Shevach, and W. Strober (ed), Current protocols in immunology. Greene Publishing Associates and Wiley-Interscience, New York.
27. Oyaizu, N., T. W. McCloskey, S. Than, R. Hu, V. S. Kalanaraman, and S. Phawa. 1994. Crosslinking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion Blood 84:2622-2631.
28. Rickinson, A. B., R. J. Murray, J. Brooks, H. Griffin, D. J. Moss, and M. G. Masucci. 1992. T cell recognition of Epstein-Barr virus associated lymphomas. Cancer Surv. 13:53-80.
29. 2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2-5-dihydroxycinnamate in fura-2-loaded human platelets. J. Biol. Chem. 268:18151-18156.
30. Savoie, A., C. Perpête, L. Carpentier, J. Joncas, and C. Alfieri. 1994 Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphopro-liferative disease. Blood 83:2715-2722.
31. Schick, M. R., V. Q. Nguyen, and S. Levy. 1993 Anti-TAPA-1 antibodies induce protein tyrosine phosphorylation that is prevented by increasing intracellular thiol levels. J. Immunol. 151:1918-1925.
32. 31a.Tanner, J. Unpublished data.
33. Tanner, J., and G. Tosato. 1991. Impairment of natural killer functions by interleukin-6 increases lymphoblastoid cell tumorigenicity in athymic mice. J. Clin. Invest. 88:239-247.
34. Tanner, J., J. Weis, D. Fearon, Y. Whang, and E. Kieff. 1987. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis Cell 50:203-213.
35. Tanner, J., Y. Whang, J. Sample, A. Sears, and E. Kieff. 1988. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J. Virol. 62:4452-4464.
36. Tanner, J. E., and J. Menezes. 1994. Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease. Blood 84:3956-3964.
37. Tanner, J. E., and G. Tosato. 1992. Regulation of B-cell growth and immunoglobulin gene transcription by interleukin-6. Blood 79:452-459.
38. Tedder, T. F., L. T. Clement, and M. D. Cooper. 1984. Expression of C3d receptors during B cell differentiation: immunofluorescence analysis with HB-5 monoclonal antibody. J. Immunol 133:678-684.
39. Tedder, T. F., L.-J. Zhou, and P. Engel. 1994. The CD19/21 signal transduction complex of B lymphocytes. Immunol Today 15:437-442.
40. Thorley-Lawson, D. A., and K. P. Mann. 1985. Early events in Epstein-Barr virus infection provide a model for B cell activation. J. Exp Med. 162:45-59.
41. Tosato, G., K. Jones, M. K. Breinig, P. McWilliams, and J. McKnight. 1993. Interleukin-6 production in posttransplant lymphoproliferative disease. J. Clin. Invest. 91:2806-2814.
42. Tosato, G., J. Tanner, K. D. Jones, M. Revel, and S. E. Pike. 1990 Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr Virus-immortalized B cells. J Virol 64:3033-3041.
43. Toullec, D., P. Painetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, and J. Kirilovsky. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol. Chem. 266:15771-15781.
44. Tsokos, G. C., J. D. Lambris, F. D. Finkelman, E. D. Anastassiou, and C. H. June. 1990 Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentrations J. Immunol. 144:1640-1645.
45. src in rat kidney cells infected with Rous sarcoma virus. Mol. Cell. Biol. 6:2198-2206.
46. Welkowitz, J., R. B. Ewen, and J. Cohen. 1982. Nonparametric and distribution-free methods, p. 291-316. In Introductory statistics for the behavioral sciences. 3rd ed. Harcourt Brace Jovanovich, New York